Topical viscous budesonide suspension for treatment of eosinophilic esophagitis - PubMed (original) (raw)
Case Reports
Topical viscous budesonide suspension for treatment of eosinophilic esophagitis
Seema S Aceves et al. J Allergy Clin Immunol. 2005 Sep.
No abstract available
Similar articles
- Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Aceves SS, Bastian JF, Newbury RO, Dohil R. Aceves SS, et al. Am J Gastroenterol. 2007 Oct;102(10):2271-9; quiz 2280. doi: 10.1111/j.1572-0241.2007.01379.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581266 - Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Dohil R, et al. Gastroenterology. 2010 Aug;139(2):418-29. doi: 10.1053/j.gastro.2010.05.001. Epub 2010 May 7. Gastroenterology. 2010. PMID: 20457157 Clinical Trial. - Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, Bussmann C, Beglinger C, Schoepfer A, Simon HU. Straumann A, et al. Gastroenterology. 2010 Nov;139(5):1526-37, 1537.e1. doi: 10.1053/j.gastro.2010.07.048. Epub 2010 Aug 1. Gastroenterology. 2010. PMID: 20682320 Clinical Trial. - Eosinophilic esophagitis: treatment with oral viscous budesonide.
Zur E. Zur E. Int J Pharm Compd. 2012 Jul-Aug;16(4):288-93. Int J Pharm Compd. 2012. PMID: 23050387 Review. - Eosinophilic esophagitis.
Franciosi JP, Liacouras CA. Franciosi JP, et al. Immunol Allergy Clin North Am. 2009 Feb;29(1):19-27, viii. doi: 10.1016/j.iac.2008.09.001. Immunol Allergy Clin North Am. 2009. PMID: 19141338 Review.
Cited by
- Medical treatment of eosinophilic esophagitis.
Franciosi JP, Gordon M, Sinopoulou V, Dellon ES, Gupta SK, Reed CC, Gutiérrez-Junquera C, Venkatesh RD, Erwin EA, Egiz A, Elleithy A, Mougey EB. Franciosi JP, et al. Cochrane Database Syst Rev. 2023 Jul 20;7(7):CD004065. doi: 10.1002/14651858.CD004065.pub4. Cochrane Database Syst Rev. 2023. PMID: 37470293 Free PMC article. Review. - LIGHT controls distinct homeostatic and inflammatory gene expression profiles in esophageal fibroblasts via differential HVEM and LTβR-mediated mechanisms.
Manresa MC, Wu A, Nhu QM, Chiang AWT, Okamoto K, Miki H, Kurten R, Pham E, Duong LD, Lewis NE, Akuthota P, Croft M, Aceves SS. Manresa MC, et al. Mucosal Immunol. 2022 Feb;15(2):327-337. doi: 10.1038/s41385-021-00472-w. Epub 2021 Dec 13. Mucosal Immunol. 2022. PMID: 34903876 Free PMC article. - Red Between the Lines: Evolution of Eosinophilic Esophagitis as a Distinct Clinicopathologic Syndrome.
Dellon ES. Dellon ES. Dig Dis Sci. 2020 Dec;65(12):3434-3447. doi: 10.1007/s10620-020-06642-3. Epub 2020 Oct 14. Dig Dis Sci. 2020. PMID: 33052498 Free PMC article. Review. - Effect of topical swallowed steroids on the bacterial and fungal esophageal microbiota in eosinophilic esophagitis.
Benitez AJ, Tanes C, Mattei L, Hofstaedter CE, Kim DK, Gross J, Ruffner MA, Albenberg L, Spergel J, Bittinger K, Muir AB. Benitez AJ, et al. Allergy. 2021 May;76(5):1549-1552. doi: 10.1111/all.14602. Epub 2020 Oct 19. Allergy. 2021. PMID: 32990947 Free PMC article. No abstract available. - Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis.
Casiraghi A, Gennari CG, Musazzi UM, Ortenzi MA, Bordignon S, Minghetti P. Casiraghi A, et al. Pharmaceutics. 2020 Mar 1;12(3):211. doi: 10.3390/pharmaceutics12030211. Pharmaceutics. 2020. PMID: 32121553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical